IL17A and candidiasis: The IL-17 pathway regulates immunity in candida infection, probably via upregulation of proinflammatory cytokines (IL-6 and neutrophil-recruiting chemokines) among other actions, and the use of IL-17 inhibitors have was associated with an increased risk of mucocutaneous candidiasis.30